6 months ago
LLY
AnalystsEvan SeigermanEvan Seigerman's Stock Forecasts
AnalystsEvan Seigerman
Analyst Ranking
Top 24%
#1252 out of 5290 analysts
Average Return
+4.51%
Win Rate
45%40 out of 88
Risk vs Reward
Poor
Good
Evan Seigerman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Terns Pharmaceuticals IncTERN | +203.79% | $17.43 | $52.95 | 2025-11-03 - 2026-05-04 | Buy |
Disc Medicine IncIRON | +165.37% | $22.84 | $60.61 | 2023-03-22 - 2024-03-22 | Buy |
Terns Pharmaceuticals IncTERN | +92.13% | $27.56 | $52.95 | 2025-11-17 - 2026-05-04 | Buy |
Eli Lilly & CoLLY | +71.55% | $428.44 | $734.97 | 2023-05-03 - 2024-05-03 | Buy |
Structure Therapeutics IncGPCR | +69.29% | $25.56 | $43.27 | 2023-02-27 - 2024-02-28 | Buy |
Evan Seigerman Analyst Color
Get additional color on Evan Seigerman's coverage of popular stocks
7 months ago
LLY
2 years ago
LLY
2 years ago
LLY
2 years ago
LLY
3 years ago
LLY
3 years ago
LLY
5 years ago
PFE
Evan Seigerman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 12 | Hold | $140.00 | -16.34% | Maintains | 4 months ago |
Biogen IncBIIB | 16 | Hold | $196.00 | -0.23% | Maintains | 4 months ago |
Terns Pharmaceuticals IncTERN | 3 | Buy | $54.00 | +1.98% | Maintains | 6 months ago |
Eli Lilly & CoLLY | 10 | Buy | $1,200.00 | +6.64% | Maintains | 6 months ago |
Gilead Sciences IncGILD | 15 | Buy | $130.00 | +0.63% | Maintains | 10 months ago |
Vertex Pharmaceuticals IncVRTX | 14 | Buy | $530.00 | +19.98% | Maintains | 10 months ago |
Incyte CorpINCY | 9 | Sell | $60.00 | -40.73% | Maintains | 10 months ago |
Disc Medicine IncIRON | 5 | Buy | $120.00 | N/A | Maintains | a year ago |
Bristol Myers Squibb CoBMY | 11 | Hold | $61.00 | N/A | Maintains | 2 years ago |
Structure Therapeutics IncGPCR | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Mirati Therapeutics IncMRTX | 4 | Hold | $59.00 | N/A | Downgrades | 3 years ago |
Replimune Group IncREPL | 1 | Buy | $40.00 | N/A | Maintains | 4 years ago |
Regeneron Pharmaceuticals IncREGN | 9 | Buy | $788.00 | N/A | Maintains | 4 years ago |
Nuvation Bio IncNUVB | 2 | Hold | $2.50 | N/A | Downgrades | 4 years ago |
Candel Therapeutics IncCADL | 2 | Buy | $12.00 | N/A | Maintains | 4 years ago |
Pfizer IncPFE | 1 | Buy | $60.00 | N/A | Initiates Coverage On | 5 years ago |
Amgen IncAMGN | 4 | Hold | $228.00 | N/A | Initiates Coverage On | 5 years ago |
Imagenebio IncIMA | 2 | Buy | $324.00 | N/A | Maintains | 5 years ago |
Satsuma Pharmaceuticals IncSTSA | 2 | Hold | $6.50 | N/A | Upgrades | 5 years ago |
Galera Therapeutics IncGRTX | 2 | Buy | $15.00 | N/A | Upgrades | 5 years ago |
Aimmune Therapeutics IncAIMT | 3 | Hold | $34.50 | N/A | Maintains | 6 years ago |
Talphera IncTLPH | 5 | Sell | $16.80 | N/A | Maintains | 6 years ago |
Macrogenics IncMGNX | 1 | Buy | $13.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.